Eric Easom - 02 Jun 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ANTX
Reported as of: 02 Jun 2025
Net transaction value: +$10,665
SEC form: 4
Accepted by SEC: 03 Jun 2025, 16:46:15 UTC
Prior SEC filing: 28 Feb 2025
Next SEC filing: 23 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Lucy Day, Attorney-in-Fact for Eric Easom

Key filing fact

Eric Easom filed Form 4 for AN2 Therapeutics, Inc. (ANTX) on 03 Jun 2025.

Key facts

This page summarizes Eric Easom's Form 4 filing for AN2 Therapeutics, Inc. (ANTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2025, 16:46.

Change

Previous filing in this sequence was filed on 28 Feb 2025.
Current net transaction value: +$10,665.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001914503 Primary reporting owner

Easom Eric

Relationship: Chief Executive Officer, Director
Address: C/O AN2 THERAPEUTICS, INC., 1800 EL CAMINO REAL, SUITE D, MENLO PARK
Signature: /s/ Lucy Day, Attorney-in-Fact for Eric Easom
Signature date: 03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANTX transaction

Common Stock

Purchase

Transaction value: $10,665
Shares: +10,000
Change %: +4.1%
Price: $1.07
Shares after: 256,380
Date: 02 Jun 2025
Ownership: Direct
Footnotes: F1, F2

ANTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,065,766
Date: 02 Jun 2025
Ownership: See Footnote
Footnotes: F3

ANTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 97,058
Date: 02 Jun 2025
Ownership: See Footnote
Footnotes: F4

ANTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 97,058
Date: 02 Jun 2025
Ownership: See Footnote
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.05 to $1.0699 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.

Footnote F2

Includes (i) 145,250 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date and (ii) a balance of 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date.

Footnote F3

Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.

Footnote F4

Consists of shares of Common Stock held by the C. Easom Irrevocable Trust dated October 8, 2021.

Footnote F5

Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.